Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Wennink plan positions red biotechnology as a growth engine for the Dutch economy
Red biotechnology, including innovative medicines and therapies, vaccines, personalised diagnostics and advanced treatments, has the potential to become a cornerstone of the Dutch economy, combining economic growth with tangible health impact. National ambitions for...
Leiden Bio Science Park welcomes Eli Lilly with a $3 billion facility
Leiden Bio Science Park welcomes Eli Lilly, strengthening The Netherlands’ position in life sciences with a $3 billion facility. Eli Lilly and Company announced plans to build a new $3 billion facility in Katwijk, the Netherlands, which will become part of the...
Leyden Labs Secures €30 million from European Innovation Council Fund and Invest-NL
Dutch biotech Leyden Labs has raised a €30 million equity investment from the European Innovation Council (EIC) Fund and Invest-NL to accelerate the development of its PanFlu nasal spray, as well as the Company’s other mucosal pipeline and platform activities. The...